Lyell Immunopharma is a clinical-stage biotech company advancing next-generation CAR T-cell therapies for solid tumors and hematologic malignancies. Our product candidates leverage novel technology to enhance T-cell durability and efficacy, aiming for consistent long-lasting clinical responses. Founded by cell therapy pioneers, Lyell operates as a fully integrated entity from discovery to clinical evaluation, driven by values of Science, Respect, Collaboration, and Courage.
Lyell is a clinical-stage company focused on advancing next-generation CAR T-cell therapies for hematologic and solid tumors. They are seeking a Director of Clinical Quality Assurance to lead and manage clinical quality systems, ensuring GCP compliance and overseeing audits. This is a hands-on leadership role within a dynamic, fast-paced environment.
Lyell Immunopharma is a clinical-stage biotech company advancing next-generation CAR T-cell therapies for solid tumors and hematologic malignancies. Our product candidates leverage novel technology to enhance T-cell durability and efficacy, aiming for consistent long-lasting clinical responses. Founded by cell therapy pioneers, Lyell operates as a fully integrated entity from discovery to clinical evaluation, driven by values of Science, Respect, Collaboration, and Courage.
Revolution Medicines